FDA issued a Warning Letter to Inopak Ltd on 2/21/2019 as a result of this inspection.
483 Inopak Jul 2018

483 Inopak Jul 2018

$119 - Not in Stock

FDA investigators audited the Inopak - Ringwood, NJ, United States facility and issued inspectional observations (via FDA 483) on 20 Jul 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 20 Jul 2018
  • Location: Ringwood, United States
  • FEI: 1000122232
Order